標(biāo)題: Titlebook: Dopamine and Sleep; Molecular, Functiona Jaime M. Monti,S. R. Pandi-Perumal,S. Chokroverty Book 2016 Springer International Publishing Swit [打印本頁(yè)] 作者: Harrison 時(shí)間: 2025-3-21 17:29
書(shū)目名稱Dopamine and Sleep影響因子(影響力)
書(shū)目名稱Dopamine and Sleep影響因子(影響力)學(xué)科排名
書(shū)目名稱Dopamine and Sleep網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱Dopamine and Sleep網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱Dopamine and Sleep被引頻次
書(shū)目名稱Dopamine and Sleep被引頻次學(xué)科排名
書(shū)目名稱Dopamine and Sleep年度引用
書(shū)目名稱Dopamine and Sleep年度引用學(xué)科排名
書(shū)目名稱Dopamine and Sleep讀者反饋
書(shū)目名稱Dopamine and Sleep讀者反饋學(xué)科排名
作者: 合并 時(shí)間: 2025-3-21 21:47 作者: 松雞 時(shí)間: 2025-3-22 01:58 作者: 假裝是我 時(shí)間: 2025-3-22 08:22 作者: 偉大 時(shí)間: 2025-3-22 10:09
Musik als Transportmittel für Ideologieare involved in diverse functions including control of movements, reward, sleep-wakefulness and rapid eye movement sleep (REMS). Loss of these DA-ergic neurons is associated with different behavioral disorders, including Parkinson’s disease, depression, REMS behavior disorder (RBD) and notably in al作者: 確保 時(shí)間: 2025-3-22 15:21 作者: 確保 時(shí)間: 2025-3-22 18:43
HMI Strategy – Recommended Actionobiological functions controlled by DA, including the sleep-wake cycle, are mediated by the DA family, which comprises D., D., D., D. and D.?receptors. From the pharmacological point of view, compounds that bind and activate DA receptors?are significant means for the study of mechanism of action of 作者: 擁護(hù)者 時(shí)間: 2025-3-22 22:12 作者: 一窩小鳥(niǎo) 時(shí)間: 2025-3-23 03:13 作者: 煤渣 時(shí)間: 2025-3-23 05:39 作者: SOBER 時(shí)間: 2025-3-23 13:38 作者: SPECT 時(shí)間: 2025-3-23 16:15 作者: 設(shè)施 時(shí)間: 2025-3-23 19:32 作者: 遍及 時(shí)間: 2025-3-24 00:19 作者: 精美食品 時(shí)間: 2025-3-24 02:38 作者: Tremor 時(shí)間: 2025-3-24 09:55
https://doi.org/10.1007/978-3-658-16430-0de effects, which compromise the efficacy of treatment and force some patients to discontinue medication. This chapter addresses these long-term consequences to RLS treatment, which could be both disease-related and medication-related issues. In addition, this chapter briefly discusses how to manage作者: 遵循的規(guī)范 時(shí)間: 2025-3-24 11:46 作者: Relinquish 時(shí)間: 2025-3-24 15:48 作者: 帶傷害 時(shí)間: 2025-3-24 19:49 作者: 勉強(qiáng) 時(shí)間: 2025-3-25 03:09
Modulations of Ventral Tegmental Area (VTA) Dopaminergic Neurons by Hypocretins/Orexins: Implicatio the results of anatomical and functional (electrophysiological /pharmacological results) studies. Many neuroscientists are also interested in functional roles of the VTA DAergic and hcrt/ox systems in reward-motivational behavior, food intake, and nociception, and some of these results will also be briefly introduced.作者: Chauvinistic 時(shí)間: 2025-3-25 06:11
Regulation and Modulation of Depression-Related Behaviours: Role of Dopaminergic Neurons,us dopaminergic neural pathways and molecular mechanisms involved in depression. It also sheds some light on how these same neural pathways might be responsible for the disturbances in sleep and circadian rhythms experienced by patients suffering from depression.作者: Simulate 時(shí)間: 2025-3-25 09:11
from established theories to the latest research advances. Accordingly, it represents an interdisciplinary, cutting-edge guide for sleep disorder specialists, sleep researchers, psychiatrists, neurologists, pulmonologists, psychologists, and behavioral sleep medicine specialists.978-3-319-83520-4978-3-319-46437-4作者: 微不足道 時(shí)間: 2025-3-25 12:37
prevention and management of sleep disorders.Presents in-depThis book offers a comprehensive but highly readable compilation of papers on the role of dopamine in sleep and sleep disorders. Leading experts in sleep medicine, psychiatry and neuroendocrinology provide a broad perspective on the field, 作者: 一再煩擾 時(shí)間: 2025-3-25 17:19
HMI Strategy – Recommended Action. From the pharmacological point of view, compounds that bind and activate DA receptors?are significant means for the study of mechanism of action of DA controlling biological phenomena such as sleep. Here, we highlight the current knowledge regarding the role of DA receptor agonist in sleep modulation.作者: OMIT 時(shí)間: 2025-3-25 22:22
https://doi.org/10.1007/978-3-658-16430-0quences to RLS treatment, which could be both disease-related and medication-related issues. In addition, this chapter briefly discusses how to manage or minimize these issues, and alternative treatment for intractable and refractory cases of RLS.作者: 路標(biāo) 時(shí)間: 2025-3-26 01:00
The Effects of Dopamine Receptor Agonists on the Sleep-Wake Cycle,. From the pharmacological point of view, compounds that bind and activate DA receptors?are significant means for the study of mechanism of action of DA controlling biological phenomena such as sleep. Here, we highlight the current knowledge regarding the role of DA receptor agonist in sleep modulation.作者: notion 時(shí)間: 2025-3-26 07:56
Long-Term Management Problems in Restless Legs Syndrome (RLS)/Willis-Ekbom Disease (WED),quences to RLS treatment, which could be both disease-related and medication-related issues. In addition, this chapter briefly discusses how to manage or minimize these issues, and alternative treatment for intractable and refractory cases of RLS.作者: Inveterate 時(shí)間: 2025-3-26 10:10 作者: adjacent 時(shí)間: 2025-3-26 14:35 作者: anaerobic 時(shí)間: 2025-3-26 19:06
Bernd Herrmann,J?rn Sieglerschmidtus dopaminergic neural pathways and molecular mechanisms involved in depression. It also sheds some light on how these same neural pathways might be responsible for the disturbances in sleep and circadian rhythms experienced by patients suffering from depression.作者: unstable-angina 時(shí)間: 2025-3-26 23:10
Klaus Bengler,Julia Drüke,Alexandra Neukumom clinicians and researchers but now these symptoms are known to be significant predictors of morbidity, quality of life, costs of disease, and rates of institutionalization. A discussion of the clinical aspects, pathophysiology, evaluation techniques and treatment options for sleep disorders encountered with PD are presented.作者: ARM 時(shí)間: 2025-3-27 03:02 作者: compose 時(shí)間: 2025-3-27 06:39 作者: 解脫 時(shí)間: 2025-3-27 12:36 作者: 懦夫 時(shí)間: 2025-3-27 17:13 作者: AMITY 時(shí)間: 2025-3-27 18:42
Dopaminergic Transmission and Wake-Promoting Effects of Central Nervous System Stimulants,, amphetamines and modafinil, are potent wake-promoting substances in mammals and even in invertebrates such as . In mammals, the cell bodies of dopamine neurons controlling the sleep-wake cycle are located in the midbrain and brainstem. Midbrain dopamine neurons express high levels of DAT and play 作者: 水汽 時(shí)間: 2025-3-27 23:05
The Effects of Dopamine Receptor Agonists on the Sleep-Wake Cycle,obiological functions controlled by DA, including the sleep-wake cycle, are mediated by the DA family, which comprises D., D., D., D. and D.?receptors. From the pharmacological point of view, compounds that bind and activate DA receptors?are significant means for the study of mechanism of action of 作者: 初次登臺(tái) 時(shí)間: 2025-3-28 03:44
Functional Interactions Between MCHergic and Dopaminergic Neurons: Role in the Control of Wakefulney both in the nucleus accumbens and prefrontal cortex during rapid-eye-movement (REM) sleep; this DAergic activity has been involved in the generation of dreams. The melanin-concentrating hormone (MCH) is a peptide with neuromodulatory functions synthesized by neurons located in the postero-lateral 作者: 無(wú)能性 時(shí)間: 2025-3-28 07:58
Modulations of Ventral Tegmental Area (VTA) Dopaminergic Neurons by Hypocretins/Orexins: Implicatiotems will be discussed. We will first overview the (1) neurobiology of wakefulness and (2) symptoms of narcolepsy, followed by discoveries of the hcrt/ox system and hcrt/ox deficiency in narcolepsy. We will then discuss the functional links between the VTA DAergic and hcrt/ox systems, by introducing作者: 一再困擾 時(shí)間: 2025-3-28 13:45
Alteration of Biological Rhythms in Diseases of the Central Dopaminergic System: Focus on Parkinsonerations in activity, temperature and heart rate rhythms have been observed in several animal models of PD. Deposition of alpha-synuclein in the hypothalamic suprachiasmatic nuclei (SCN) (i.e, the site of central oscillator) has been detected in transgenic mice and altered rhythms in clock genes hav作者: 復(fù)習(xí) 時(shí)間: 2025-3-28 17:58 作者: 會(huì)犯錯(cuò)誤 時(shí)間: 2025-3-28 22:09 作者: Obscure 時(shí)間: 2025-3-29 01:46 作者: Interim 時(shí)間: 2025-3-29 05:53
Sleep in Schizophrenia Patients and the Effects of Second Generation Antipsychotic Drugs,TST), sleep efficiency (SE), and rapid-eye-movement (REM) sleep latency, but REM sleep percentage remain unchanged. According to polysomnographic studies, the administration of clozapine, olanzapine and paliperidone to schizophrenia patients was followed by a significant reduction of SL and an incre作者: Limited 時(shí)間: 2025-3-29 08:08
Sleep in Narcolepsy and the Effects of Modafinil, type 2), plus or minus hypnagogic hallucinations, sleep paralysis and disturbed nocturnal sleep. Narcolepsy type 1 is caused by a selective loss of hypocretin producing cells in the posterior hypothalamus. The pathogenesis is unknown but thought to be related to an autoimmune process, based on the 作者: Inveterate 時(shí)間: 2025-3-29 12:59
Long-Term Management Problems in Restless Legs Syndrome (RLS)/Willis-Ekbom Disease (WED),de effects, which compromise the efficacy of treatment and force some patients to discontinue medication. This chapter addresses these long-term consequences to RLS treatment, which could be both disease-related and medication-related issues. In addition, this chapter briefly discusses how to manage作者: 課程 時(shí)間: 2025-3-29 16:20
Dopaminergic Transmission and Wake-Promoting Effects of Central Nervous System Stimulants,se arousal by inhibiting the nucleus accumbens, by exciting wake-promoting basal forebrain cholinergic and brainstem serotonin neurons and by inhibiting sleep-promoting neurons in the preoptic hypothalamus. Dopamine acts on D. type (D., D.) and D.-type (D., D., D.) receptors. Both types are involved作者: 禁令 時(shí)間: 2025-3-29 21:52
Functional Interactions Between MCHergic and Dopaminergic Neurons: Role in the Control of Wakefulneing non-REM (NREM) sleep and reach their maximal rate during REM sleep. Although there is almost no direct information regarding the interaction between MCHergic and DAergic neurons in the control of W and sleep, indirect evidence strongly suggests an important interaction between both systems in th作者: 懶洋洋 時(shí)間: 2025-3-30 02:06
Alteration of Biological Rhythms in Diseases of the Central Dopaminergic System: Focus on Parkinsond SCN, these pieces of evidence suggest that disturbances in the circadian timing system might be part of the core features of PD and not just a “collateral damage”. According to this view, a disturbed clockwork might actively contribute to neurodegeneration and a chronotherapeutic approach to PD mi作者: 量被毀壞 時(shí)間: 2025-3-30 06:33
Depression, Sleep Disorders, and DA,nown. The evidence implicates dopamine as a neurobiological factor associated with symptoms of insomnia and depression. Dopamine is a neuromodulator that regulates reward processing, arousal states, affect, and mood regulation. However, the putative role of dopamine in insomnia and depression has la作者: 進(jìn)步 時(shí)間: 2025-3-30 08:23
Sleep in Schizophrenia Patients and the Effects of Second Generation Antipsychotic Drugs,ve been published on the effects of ziprasidone, aripiprazole, asenapine, iloperidone and lurasidone on sleep in schizophrenia patients. Somnolence is a common side-effect in patients receiving clozapine, olanzapine, asenapine and iloperidone, followed by ziprasidone and quetiapine. In contrast, ins
